Continuous versus Intermittent Infusion of Oxacillin for Treatment of Infective Endocarditis Caused by Methicillin-Susceptible Staphylococcus aureus
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Infective endocarditis (IE) is the fourth leading cause of life-threatening infection in the United States and imposes significant morbidity and mortality. The American Heart Association guidelines for the diagnosis and treatment of IE do not address continuous-infusion (CI) oxacillin. This retrospective study compares outcomes between CI oxacillin and intermittent-infusion (II) oxacillin in the treatment of IE caused by methicillin-susceptible Staphylococcus aureus (MSSA). A total of 709 medical records were reviewed for inpatients with definitive IE treated between 1 January 2000 and 31 December 2007. Continuous data were analyzed by Student's t test or the Wilcoxon rank sum test. The chi-square test or Fisher's exact test was used to compare nominal data. A multivariate logistic model was constructed. One hundred seven patients met eligibility criteria for inclusion into the study. Seventy-eight patients received CI oxacillin, whereas 28 received II oxacillin. CI and II groups were similar with respect to 30-day mortality (8% versus 10%, P = 0.7) and length of stay (20 versus 25 days, P = 0.4) but differed in 30-day microbiological cure (94% versus 79%, P = 0.03). Sixty-three patients received synergistic gentamicin, whereas 44 did not. The gentamicin and no-gentamicin groups were similar with respect to 30-day mortality (11% versus 4%, P = 0.2) and 30-day microbiological cure (90% versus 89%, P = 0.8); however, times to defervescence (4 versus 2 days, P = 0.02) were significantly different. CI oxacillin is an effective alternative to II oxacillin for the treatment of IE caused by MSSA and may improve microbiological cure. This convenient and pharmacodynamically optimized dosing regimen for oxacillin deserves consideration for patients with IE caused by MSSA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Proposed Modifications to the Duke Criteria for the Diagnosis of Infective Endocarditis
Li, J. S., Sexton, D. J., Mick, N., Nettles, R., Fowler, V. G., Ryan, T., Bashore, T., & Corey, G. R. (2000) · Clinical Infectious Diseases · doi:10.1086/313753 · Cited by 4,027
Durack, D. T., Lukes, A. S., Bright, D. K., & Service, D. E. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90143-0 · Cited by 2,572
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
Fowler, V. G., Boucher, H. W., Corey, G. R., Abrutyn, E., Karchmer, A. W., Rupp, M. E., Levine, D. P., Chambers, H. F., Tally, F. P., Vigliani, G. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053783 · Cited by 1,459
Infective Endocarditis in Adults
Mylonakis, E., & Calderwood, S. B. (2001) · New England Journal of Medicine · doi:10.1056/nejmra010082 · Cited by 1,324
Staphylococcus aureus Endocarditis: A Consequence of Medical Progress
Fowler, V. G., Miro, J. M., Hoen, B., Cabell, C. H., Abrutyn, E., Rubinstein, E., Corey, G. R., Spelman, D., Bradley, S. F., Barsic, B., et al. (2005) · JAMA · doi:10.1001/jama.293.24.3012 · Cited by 1,174
Changing Profile of Infective Endocarditis<SUBTITLE>Results of a 1-Year Survey in France</SUBTITLE>
Hoen, B. (2002) · JAMA · doi:10.1001/jama.288.1.75 · Cited by 987
Diagnosis and Management of Infective Endocarditis and Its Complications
Bayer, A. S., Bolger, A. F., Taubert, K. A., Wilson, W., Steckelberg, J., Karchmer, A. W., Levison, M., Chambers, H. F., Dajani, A. S., Gewitz, M. H., et al. (1998) · Circulation · doi:10.1161/01.cir.98.25.2936 · Cited by 759
The Pharmacodynamics of β‐Lactams
Turnidge, J. D. (1998) · Clinical Infectious Diseases · doi:10.1086/514622 · Cited by 593
Research works printed but not linked: 1
- Practice Management Information Corporation 2008 vol. 1
Cited by
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Are bloodstream leukocytes Trojan Horses for the metastasis of Staphylococcus aureus?
Thwaites, G. E., & Gant, V. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2508 · Cited by 320
Clinical management of Staphylococcus aureus bacteraemia
Thwaites, G. E., Edgeworth, J. D., Gkrania-Klotsas, E., Kirby, A., Tilley, R., Török, M. E., Walker, S., Wertheim, H. F., Wilson, P., & Llewelyn, M. J. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70285-1 · Cited by 261
Serna-Galvis, E. A., Silva-Agredo, J., Giraldo-Aguirre, A. L., Flórez-Acosta, O. A., & Torres-Palma, R. A. (2016) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2016.01.007 · Cited by 131
Serna-Galvis, E. A., Silva, J., Giraldo-Aguirre, A. L., Flórez, O. A., & Torres-Palma, R. A. (2015) · Chemical Engineering Journal · doi:10.1016/j.cej.2015.08.154 · Cited by 111
Management of Staphylococcus aureus bacteremia and endocarditis: progresses and challenges
Kern, W. V. (2010) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32833bcc8a · Cited by 102
Craig, W. A. (2010) · Critical Care Clinics · doi:10.1016/j.ccc.2010.11.006 · Cited by 99
Teo, J. Q.-M., Liew, Y., Lee, W., & Kwa, A. L. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.01.027 · Cited by 106
Drug Therapy in Patients With Chronic Renal Failure
Hartmann, B., Czock, D., & Keller, F. (2010) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2010.0647 · Cited by 87
Berti, A. D., Sakoulas, G., Nizet, V., Tewhey, R., & Rose, W. E. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00594-13 · Cited by 87
Managing infective endocarditis in the elderly: new issues for an old disease
Forestier, E., Fraisse, T., Baudron, C. R., Selton‐Suty, C., & Pagani, L. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s101902 · Cited by 73
Rieg, S., Joost, I., Weiß, V., Peyerl‐Hoffmann, G., Schneider, C., Hellmich, M., Seifert, H., Kern, W. V., & Kaasch, A. J. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.08.026 · Cited by 61
(2012) · PubMed · Cited by 59
Amodeo, M. R., Clulow, T., Lainchbury, J. G., Murdoch, D., Gallagher, K., Dyer, A., Metcalf, S. C. L., Pithie, A. D., & Chambers, S. T. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.09.009 · Cited by 64
Herendael, B. V., Jeurissen, A., Tulkens, P. M., Vlieghe, E., Verbrugghe, W., Jorens, P. G., & Ieven, M. M. (2012) · Annals of Intensive Care · doi:10.1186/2110-5820-2-22 · Cited by 66
Revisiting Beta-lactams – PK/PD improves dosing of old antibiotics
MacGowan, A. P. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.07.006 · Cited by 54
Advances in the therapy of bacterial bloodstream infections
Giannella, M., Bartoletti, M., Gatti, M., & Viale, P. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.11.001 · Cited by 52
Giraldo-Aguirre, A. L., Erazo-Erazo, E. D., Flórez-Acosta, O. A., Serna-Galvis, E. A., & Torres-Palma, R. A. (2015) · Journal of Photochemistry and Photobiology A Chemistry · doi:10.1016/j.jphotochem.2015.06.021 · Cited by 49
Pinto, H. B., Brust, F. R., Macêdo, A. J., & Trentin, D. D. S. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104571 · Cited by 41
Chua, K., & Howden, B. P. (2009) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328331fbcd · Cited by 40
A comparison of different antibiotic regimens for the treatment of infective endocarditis
Martí-Carvajal, A. J., Dayer, M., Conterno, L. D. O., Garay, A. G. G., Martí-Amarista, C. E., & Simancas‐Racines, D. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009880.pub2 · Cited by 35
Use of Nanoparticles as Therapy for Methicillin-Resistant Staphylococcus aureus Infections
Liu, P., Lo, C., Chen, C., Hsieh, M., & Huang, C. (2009) · Current Drug Metabolism · doi:10.2174/138920009790274522 · Cited by 34
Sandberg, A., Jensen, K. S., Baudoux, P., Françoise Van Bambeke, A., Tulkens, P. M., & Møller, J. K. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01400-09 · Cited by 32
Becker, P., Hakenbeck, R., & Henrich, B. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01485-08 · Cited by 27
Suwannaruang, T., Kidkhunthod, P., Butburee, T., Shivaraju, H. P., Shahmoradi, B., & Wantala, K. (2021) · Surfaces and Interfaces · doi:10.1016/j.surfin.2021.101013 · Cited by 24
Gatti, M., Viaggi, B., Rossolini, G. M., Pea, F., & Viale, P. (2023) · Microorganisms · doi:10.3390/microorganisms11020394 · Cited by 17
Verdier, M., Tribut, O., Tattevin, P., Michelet, C., & Bentué‐Ferrer, D. (2011) · Journal of Chemotherapy · doi:10.1179/joc.2011.23.5.277 · Cited by 16
Keller, F., Schröppel, B., & Ludwig, U. (2015) · World Journal of Nephrology · doi:10.5527/wjn.v4.i3.330 · Cited by 17
Nesseler, N., Verdier, M., Launey, Y., Malherbe, A., Dermu, M., Piau, C., Flecher, E. M., Tribut, O., Mallédant, Y., & Séguin, P. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02624-14 · Cited by 13
Courjon, J., Garzaro, M., Roger, P., Ruimy, R., Lavrut, T., Chelli, M., Raynier, J.-L., Chirio, D., Demonchy, É., Cabane, L., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01562-20 · Cited by 14
Role of intravenous cloxacillin for inpatient infections
Bru, J. P., & Garraffo, R. (2012) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2011.10.015 · Cited by 13
Ogawa, T., Sato, M., Yonekawa, S., Nakagawa, C., Uno, K., Kasahara, K., Maeda, K., Konishi, M., & Mikasa, K. (2013) · Internal Medicine · doi:10.2169/internalmedicine.52.8425 · Cited by 13
Tiseo, G., Arena, F., Borrè, S., Campanile, F., Falcone, M., Mussini, C., Pea, F., Sganga, G., Stefani, S., & Venditti, M. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1926986 · Cited by 13
Leggett, J. E. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00025-4 · Cited by 15
Brown, D., & MacGowan, A. P. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp432 · Cited by 11
Calderón‐Parra, J., Grillo, S., Muñóz, P., Machado-Vílchez, M., Delgado-Montero, A., de Alarcón, A., Borrego, M. P., Goenaga-Sánchez, M. Á., Fariñas, M. C., Miró, J. M., et al. (2024) · Journal of Infection · doi:10.1016/j.jinf.2024.106352 · Cited by 7
Staphylococcus-aureus-Blutstrominfektion – eine interdisziplinäre Herausforderung
Hagel, S., Kaasch, A. J., Weis, S., Seifert, H., Pletz, M. W., & Rieg, S. (2019) · AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie · doi:10.1055/a-0756-8263 · Cited by 8
Ogawa, T., Kasahara, K., Ikawa, K., Shigeta, J., Komatsu, Y., Kuruno, N., Uno, K., Maeda, K., & Mikasa, K. (2014) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2014.05.006 · Cited by 6
Bauer, K. A. A., Gentene, A. J., West, J. E., Shidham, G. B., & Goff, D. A. (2013) · Infectious Diseases in Clinical Practice · doi:10.1097/ipc.0b013e318278f539 · Cited by 5
Gupta, R., Kaushal, V., Goyal, A., Kumar, P., Gupta, D., Tandon, R., Mahajan, A., Singla, S., Singh, G., Singh, B., et al. (2021) · Indian Heart Journal · doi:10.1016/j.ihj.2021.10.013 · Cited by 6
Introduction to Pharmacodynamics
Craig, W. A. (2013) · Springer eBooks · doi:10.1007/978-0-387-75613-4_1 · Cited by 8
Optimizing Betalactam Clinical Response by Using a Continuous Infusion: A Comprehensive Review
Diamantis, S., Chakvetadze, C., de Pontfarcy, A., & Matta, M. (2023) · Antibiotics · doi:10.3390/antibiotics12061052 · Cited by 4
Antibiotic therapy for treatment of infective endocarditis
Martí-Carvajal, A. J., Conterno, L. D. O., Hidalgo, R., Kwong, J. S., Georgoulas, P., & Salanti, G. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009880 · Cited by 4
Farahani, P., Ruffin, F., Taherahmadi, M., Webster, M. E., Korn, R. E., Cantrell, S. E., Wahid, L., Fowler, V. G., & Thaden, J. T. (2024) · Microorganisms · doi:10.3390/microorganisms12112226 · Cited by 3
Clinical Outcomes With Continuous Nafcillin Infusions in Children
Knoderer, C. A., Karmire, L. C., & Nichols, K. R. (2017) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-22.4.261 · Cited by 3
Pharmakotherapie bei niereninsuffizienten Patienten und unter Dialysebehandlung
Maus, S., & Keller, F. (2011) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Tratamiento conservador de abscesos cerebrales secundarios a endocarditis estafilocócica
Cobos‐Carrascosa, E., Forte, M. S., Sánchez, F. G., & Montes, M. (2011) · Anales de Pediatría · doi:10.1016/j.anpedi.2011.07.032
Abdul-Aziz, M. H. (2016) · The University of Queensland · doi:10.14264/uql.2016.450
Prolonged oxacillin infusion in a patient with staphylococcal bacteraemia
Vodička, M., & Ryšavý, I. (2020) · Klinická farmakologie a farmacie · doi:10.36290/far.2019.038
Tabuena, R. P., Arinzol, S., Tabuena, M. D., & Libanan, L. L. (2024) · Philippine journal of chest diseases · doi:10.70172/pjcd.v22i2.9817
Jiang, L., Lin, Z., Wu, S., & Chen, T. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1539372
Metadata
- Authors
- Hughes, D. W., Frei, C. R., Maxwell, P. R., Green, K., Patterson, J. E., Crawford, G. E., & Lewis, J. S.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- University Health System (US)
- Corresponding author
- Lewis, James S.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2009-05
- Volume
- 53
- Issue
- 5
- Pages
- 2014-2019
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC2681516
- OpenAlex
- W2049490144
- Semantic Scholar
- 0c3bfe27003ccf8d6cdbf7394089cba522607677
- Cited by
- 52
- References
- 23
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 2 · 2022: 1 · 2021: 3 · 2020: 3 · 2019: 2 · 2017: 1 · 2016: 5 · 2015: 5 · 2014: 3 · 2013: 4 · 2012: 4
- FWCI
- 4.25
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Texas ScholarWorks (Texas Digital Library) (submittedVersion, other-oa)
- Funders
- American Heart Association
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Keywords
- infective endocarditis, oxacillin, continuous infusion, intermittent infusion, methicillin-susceptible Staphylococcus aureus, microbiological cure, gentamicin, antibiotic dosing regimens, 30-day mortality, length of hospital stay, defervescence
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Anti-Bacterial Agents, Drug Administration Schedule, Endocarditis, Bacterial, Female, Humans, Infusions, Intravenous, Male, Methicillin, Microbial Sensitivity Tests, Middle Aged, Oxacillin, Staphylococcal Infections, Staphylococcus aureus, Treatment Outcome, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.